Thirty-day readmissions in hospitalized patients who received bezlotoxumab with antibacterial drug treatment for Clostridium difficile infection

Authors

Vimalanand S. Prabhu, Merck & Co., Inc.
Oliver A. Cornely, University of Cologne
Yoav Golan, , Tufts University
Erik R. Dubberke, Washington University School of Medicine in St. Louis
Sebastian M. Heimann, University Hospital of Cologne
Mary E. Hansen, Infectious Diseases & Vaccines
Jane Liao, Statistical Programming for Center for Outcomes Research Excellence
Alison Pedley, Late Development Statistics
Mary Beth Dorr, Infectious Diseases, and.
Stephen Marcella, Merck & Co., Inc.

Journal

Clinical Infectious Diseases

Publication Date

2017

Volume

65

Issue

7

First Page

1218

Last Page

1221

Document Type

Open Access Publication

DOI

doi: 10.1093/cid/cix523

Rights and Permissions

Vimalanand S Prabhu, Oliver A Cornely, Yoav Golan, Erik R Dubberke, Sebastian M Heimann, Mary E Hanson, Jane Liao, Alison Pedley, Mary Beth Dorr, Stephen Marcella, Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection, Clinical Infectious Diseases, Volume 65, Issue 7, 1 October 2017, Pages 1218–1221, https://doi.org/10.1093/cid/cix523. © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. https://academic.oup.com/cid/article/65/7/1218/4080783.

Recommended Citation

Prabhu, Vimalanand S.; Cornely, Oliver A.; Golan, Yoav; Dubberke, Erik R.; Heimann, Sebastian M.; Hansen, Mary E.; Liao, Jane; Pedley, Alison; Dorr, Mary Beth; and Marcella, Stephen, "Thirty-day readmissions in hospitalized patients who received bezlotoxumab with antibacterial drug treatment for Clostridium difficile infection." Clinical Infectious Diseases. 65, 7. 1218 - 1221. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/8464